Learn how AOD 9604 fat loss research works, typical dosage protocols, safety concerns, and why this peptide is not FDA-approved for human use.
AOD 9604 is a synthetic peptide fragment of human growth hormone that researchers have studied for fat loss, mainly because it may stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage). It is not FDA-approved for human use in the United States, and human evidence for meaningful fat loss is limited. Anyone considering AOD 9604 should speak with a healthcare professional before using it.
What Is AOD 9604?
AOD 9604 (also written AOD-9604) is a modified piece of human growth hormone. It corresponds to the C-terminal fragment of HGH, covering amino acids 176 through 191.
Scientists designed this fragment to isolate growth hormone's effects on fat metabolism without raising IGF-1 levels or affecting blood sugar. In research settings, AOD 9604 is classified as a peptide hormone and is banned by the World Anti-Doping Agency (WADA).
AOD 9604 is not a prescription weight-loss drug. It is sold online as a research chemical, often labeled 'not for human consumption.'
How AOD 9604 May Support Fat Loss
Early laboratory and animal studies suggest AOD 9604 may influence fat cells in several ways:
- Stimulates lipolysis: It may encourage fat cells to release stored fat for energy.
- Inhibits lipogenesis: It may reduce the formation of new fat cells.
- Targets beta-adrenergic pathways: Some research points to beta-3 adrenergic receptor activity, which is involved in fat breakdown.
- Spares blood sugar: Unlike full HGH, AOD 9604 does not appear to raise blood glucose or IGF-1 in short-term studies.
Human trials have been mixed. Some early studies reported modest reductions in fat mass, but a larger Phase IIb trial did not meet all of its efficacy goals. That means claims about AOD 9604 fat loss should be viewed with caution.
AOD 9604 Dosage Protocol and Administration
There is no FDA-approved AOD 9604 dosage protocol for humans. In research and anecdotal settings, common practices include:
| Protocol Element | Common Research Practice |
|---|---|
| Dose | 250–500 mcg per day |
| Route | Subcutaneous injection |
| Timing | Morning, often fasted |
| Frequency | Once daily, though some split into two doses |
| Cycle length | 4–12 weeks (anecdotal, not established) |
Users often ask about dosing frequency; the typical answer in online communities is once per day. However, no standard human dose has been established, and more frequent dosing is not necessarily better.
Because AOD 9604 has a short half-life, some users inject before cardio or fasting to try to amplify fat oxidation. This strategy is not supported by strong clinical evidence.
AOD 9604 vs MOTS-c: How They Compare
AOD 9604 and MOTS-c are both research peptides studied for metabolic effects, but they work through different mechanisms. AOD 9604 focuses on fat breakdown and storage, while MOTS-c is a mitochondrial-derived peptide linked to insulin sensitivity and cellular energy.
| Feature | AOD 9604 | MOTS-c |
|---|---|---|
| Origin | Synthetic HGH fragment (aa 176–191) | Mitochondrial-derived peptide |
| Main research interest | Fat loss, lipolysis | Metabolic health, insulin sensitivity |
| Typical research dose | 250–500 mcg daily | 5–10 mg per week, often split |
| Injection frequency | Once daily | 2–3 times weekly |
| FDA approval | Not approved for human use | Not approved for human use |
Anyone comparing aod 9604 vs mots-c should note that neither peptide is approved for human use, and both are banned in sport.
Reconstituting AOD 9604 and Avoiding 'Gelling Up'
AOD 9604 usually comes as a lyophilized powder that must be mixed with bacteriostatic water before injection. Proper technique matters.
- Clean the rubber stoppers with an alcohol swab.
- Draw bacteriostatic water into a syringe.
- Inject the water slowly down the inside wall of the vial, not directly onto the powder.
- Swirl the vial gently. Never shake it.
- Refrigerate the reconstituted peptide and use it within the recommended window.
If you see aod-9604 gelling up, clumping, or cloudiness, the peptide may be degraded or improperly mixed. Avoid using a solution that looks gel-like or has visible particles.
Many users search for step-by-step reconstitution guides, but the core steps are the same: slow mixing, gentle swirling, and cold storage. Always use sterile technique to reduce infection risk.
Safety, Side Effects, and Legal Status
AOD 9604 is not FDA-approved for human use in the United States. It is sold as a research chemical, and products marketed to consumers may be unregulated, impure, or mislabeled.
Reported side effects from anecdotal use include:
- Injection site pain, redness, or swelling
- Headache
- Nausea
- Fatigue
Long-term safety data in humans are lacking. AOD 9604 is also on the WADA prohibited list, so athletes should avoid it.
If you want to buy aod-9604 peptide, understand that the legal status is gray. The FDA has not approved it for any human condition, and selling it for human use is not permitted.
What Do AOD 9604 Reviews Say?
aod 9604 reviews from users are mixed. Some people report reduced appetite or visible fat loss, while others notice no change. Anecdotal reports are not reliable evidence because they lack controls, blinding, and standardized dosing.
Factors like diet, exercise, sleep, and genetics have a much larger impact on fat loss than any single peptide. Placebo effects are also common in self-reported peptide use.
Bottom Line on AOD 9604 for Fat Loss
AOD 9604 is a research peptide with a plausible mechanism for fat loss, but human evidence is limited and it is not FDA-approved. It is not a substitute for a calorie deficit, resistance training, and adequate sleep.
If you have questions about AOD 9604 or any fat-loss peptide, talk with a licensed healthcare professional. They can help you weigh potential risks against unproven benefits.
Frequently Asked Questions
Does AOD 9604 actually burn fat?
Research suggests AOD 9604 may stimulate lipolysis and inhibit fat storage, but human trials have been mixed and it is not FDA-approved. Any fat loss from the peptide alone is likely modest compared with diet and exercise.
What is the typical AOD 9604 dosage?
Anecdotal and research protocols often use 250–500 mcg per day by subcutaneous injection. No standard human dose exists, and higher doses are not proven to work better. Consult a healthcare professional before using it.
Is AOD 9604 legal to buy in the US?
AOD 9604 is not FDA-approved for human use, so it is sold as a research chemical rather than a supplement or drug. Buying it for personal use occupies a legal gray area, and products may be unregulated.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.